Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析

◆英語タイトル:Reitmans (Canada) Limited (RET.A) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8010468
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月27日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:小売
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Reitmans (Canada) Limited (RET.A) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Reitmans (Canada) Limited (RCL) is a specialty apparel retailer that primarily merchandise and sells tops, dresses, skirts, pants, sweaters, shirts, blouses, sweaters, lingerie, footwear and accessories through its specialty retail outlets. These stores are primarily located in various major shopping malls, busy retail outlets and retail power centers across Canada. The company markets and sells these products under Reitmans, Penningtons, Addition Elle, RW & CO, Thyme Maternity and Hyba. It operates these stores in various cities and towns of Newfoundland, Prince Edward Island, Nova Scotia, New Brunswick, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Northwest Territories, and Yukon. The company also merchandises these products through its e-commerce portals reitmans.com, penningtons.com, additionelle.com, rw-co.com, thymematernity.com and hyba.ca. RCL is headquartered in Montreal, Canada.

Reitmans (Canada) Limited Key Recent Developments

Nov 30,2017: Reitmans (Canada) Limited announces its results for the three and nine months ended October 28, 2017
May 30,2017: Reitmans (Canada) Limited announces its results for the three months ended April 29, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Reitmans (Canada) Limited – Key Facts 5
Reitmans (Canada) Limited – Key Employees 6
Reitmans (Canada) Limited – Major Products and Services 8
Reitmans (Canada) Limited – History 9
Reitmans (Canada) Limited – Company Statement 10
Reitmans (Canada) Limited – Locations And Subsidiaries 11
Head Office 11
Section 2 – Company Analysis 12
Company Overview 12
Reitmans (Canada) Limited – Business Description 12
Reitmans (Canada) Limited – Corporate Strategy 13
Reitmans (Canada) Limited – SWOT Analysis 14
SWOT Analysis – Overview 14
Reitmans (Canada) Limited – Strengths 14
Reitmans (Canada) Limited – Weaknesses 15
Reitmans (Canada) Limited – Opportunities 16
Reitmans (Canada) Limited – Threats 17
Reitmans (Canada) Limited – Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios – Capital Market Ratios 19
Financial Ratios – Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Section 4 – Company’s Recent Developments 26
Nov 30, 2017: Reitmans (Canada) Limited announces its results for the three and nine months ended October 28, 2017 26
May 30, 2017: Reitmans (Canada) Limited announces its results for the three months ended April 29, 2017 28
Dec 02, 2016: Reitmans Limited announces results for three and nine months ended October 29, 2016 29
Sep 28, 2016: Reitmans announces appointment of new director 30
Sep 09, 2016: Reitmans announces its results for the three and six months ended July 30, 2016 31
Jun 01, 2016: Reitmans announces its results for the three months ended April 30, 2016 32
Apr 13, 2016: Reitmans (Canada) limited welcomes new executives 33
Mar 30, 2016: Reitmans (Canada) limited announces year-end results 34
Section 5 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Reitmans (Canada) Limited, Key Facts 5
Reitmans (Canada) Limited, Key Employees 6
Reitmans (Canada) Limited, Major Products and Services 8
Reitmans (Canada) Limited, History 9
Reitmans (Canada) Limited, Key Competitors 18
Reitmans (Canada) Limited, Ratios based on current share price 19
Reitmans (Canada) Limited, Annual Ratios 20
Reitmans (Canada) Limited, Annual Ratios (Cont...1) 21
Reitmans (Canada) Limited, Annual Ratios (Cont...2) 22
Reitmans (Canada) Limited, Interim Ratios 24
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

★海外企業調査レポート[Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lensar Inc:医療機器:M&Aディール及び事業提携情報
    Summary Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers vari …
  • Alstom SA (ALO):企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Arena Pharmaceuticals Inc (ARNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes small molecule drugs in multiple therapy areas. It is evaluating its lead candidate etrasimod for multiple inflammatory indications including ulcerative colitis, primary biliary chol …
  • China Resources Pharmaceutical Group Ltd (3320):製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …
  • Take-Two Interactive Software, Inc.
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Morneau Shepell Inc.
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kezar Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kezar Life Sciences Inc (Kezar) is a biotech company that discovers and develops therapies for protein homeostasis. The company’s development program includes KZR-616, a selective small molecule inhibitor of the immunoproteasome. Its KZR-616 finds application in the treatment of autoimmune d …
  • Toleranzia AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Toleranzia AB (Toleranzia) is a drug developer that utilizes immune system’s intrinsic power to treat autoimmune diseases. The company offers products and technologies including Re-Tolerogen for the treatment of autoimmune diseases. Its Re-Tolerogen platform technology is a fusion protein fo …
  • Psychemedics Corp (PMD):企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) is a clinical laboratory service provider. The company provides testing for drugs abuse using hair analysis. It offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzod …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Immuno-Biological Laboratories Co Ltd (4570):製薬・医療:M&Aディール及び事業提携情報
    Summary Immuno-Biological Laboratories Co Ltd (IBL) is a pharmaceutical company that develops, manufactures and markets diagnostic products. The company provides business areas such as diagnostic and research reagents, customized services, global sales network, protein production business using tran …
  • Lawson Inc:企業の戦略・SWOT・財務分析
    Lawson Inc - Strategy, SWOT and Corporate Finance Report Summary Lawson Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vulcan Materials Company:企業の戦略・SWOT・財務分析
    Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report Summary Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Marui Group Co Ltd:企業の戦略・SWOT・財務分析
    Marui Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Marui Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AxoGen Inc (AXGN):企業の財務・戦略的SWOT分析
    Summary AxoGen Inc (AxoGen) formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company's products include AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among other …
  • Svenska Petroleum Exploration AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Svenska Petroleum Exploration AB (Svenska Petroleum), a subsidiary of Petroswede AB is an oil and gas company that offers offshore oil exploration and production. The company operates 3D Sendji data and acquisition of new 3D data in Kaba area to explore for the pre-salt. It has oil and gas p …
  • Diagnostica Stago SAS:企業の戦略的SWOT分析
    Diagnostica Stago SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • TG Therapeutics Inc (TGTX):製薬・医療:M&Aディール及び事業提携情報
    Summary TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company develops two therapies, namely, TG-1101 (ublituximab) and TGR-1202 for the tr …
  • Allied Hotel Properties Inc:企業の戦略・SWOT・財務情報
    Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Advanced Medical Electronics Corp:製品パイプライン分析
    Summary Advanced Medical Electronics Corp (AME) is a medical device company that offers research and development services. The company provides electrocardiograph and spirometer equipment. It provides battery powered surgical headlamp, oximeter, partial polysomnograph, and computerized visual acuity …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆